{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:57:11Z","timestamp":1791910631082,"version":"4.3.4"},"reference-count":91,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Education, Culture, Sports, Science and Technology of Japan","award":["22K15604"],"award-info":[{"award-number":["22K15604"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Reprogramming of energy metabolism to support cellular growth is a \u201challmark\u201d of cancer, allowing cancer cells to balance the catabolic demands with the anabolic needs of producing the nucleotides, amino acids, and lipids necessary for tumor growth. Metabolic alterations, or \u201caddiction\u201d, are promising therapeutic targets and the focus of many drug discovery programs. Asparagine metabolism has gained much attention in recent years as a novel target for cancer therapy. Asparagine is widely used in the production of other nutrients and plays an important role in cancer development. Nutritional inhibition therapy targeting asparagine has been used as an anticancer strategy and has shown success in the treatment of leukemia. However, in solid tumors, asparagine restriction alone does not provide ideal therapeutic efficacy. Tumor cells initiate reprogramming processes in response to asparagine deprivation. This review provides a comprehensive overview of asparagine metabolism in cancers. We highlight the physiological role of asparagine and current advances in improving survival and overcoming therapeutic resistance.<\/jats:p>","DOI":"10.3390\/nu17010179","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T05:02:02Z","timestamp":1735880522000},"page":"179","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Targeting Asparagine Metabolism in Solid Tumors"],"prefix":"10.3390","volume":"17","author":[{"given":"Keita","family":"Hanada","sequence":"first","affiliation":[{"name":"Department of Gastrointestinal Surgery, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan"},{"name":"Department of Surgery, Rakuwakai Otowa Hospital, Kyoto 607-8062, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4336-6937","authenticated-orcid":false,"given":"Kenji","family":"Kawada","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan"},{"name":"Department of General Surgery, Kurashiki Central Hospital, Kurashiki 710-8602, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2924-6701","authenticated-orcid":false,"given":"Kazutaka","family":"Obama","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1084\/jem.98.6.583","article-title":"Regression of transplanted lymphomas induced in vivo by means of normal guinea pig serum. II. Studies on the nature of the active serum constituent: Histological mechanism of the regression: Tests for effects of guinea pig serum on lymphoma cells in vitro: Discussion","volume":"98","author":"Kidd","year":"1953","journal-title":"J. Exp. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1084\/jem.118.1.99","article-title":"Evidence that the L-asparaginase of guinea pig serum is responsible for its antilymphoma effects. I. Properties of the L-asparaginase of guinea pig serum in relation to those of the antilymphoma substance","volume":"118","author":"Broome","year":"1963","journal-title":"J. Exp. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1084\/jem.118.1.121","article-title":"Evidence that the L-asparaginase of guinea pig serum is responsible for its antilymphoma effects. II. Lymphoma 6C3HED cells cultured in a medium devoid of L-asparagine lose their susceptibility to the effects of guinea pig serum in vivo","volume":"118","author":"Broome","year":"1963","journal-title":"J. Exp. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"19952","DOI":"10.1074\/jbc.R117.819060","article-title":"Asparagine synthetase: Function, structure, and role in disease","volume":"292","author":"Lomelino","year":"2017","journal-title":"J. Biol. Chem."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1042\/bj3570321","article-title":"Asparagine synthetase expression alone is sufficient to induce l-asparaginase resistance in MOLT-4 human leukaemia cells","volume":"357","author":"Aslanian","year":"2001","journal-title":"Biochem. J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/pbc.21213","article-title":"Correlation between asparaginase sensitivity and asparagine synthetase protein content, but not mRNA, in acute lymphoblastic leukemia cell lines","volume":"50","author":"Su","year":"2008","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1021\/acsptsci.0c00196","article-title":"Therapeutic Assessment of Targeting ASNS Combined with l-Asparaginase Treatment in Solid Tumors and Investigation of Resistance Mechanisms","volume":"4","author":"Apfel","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"ref_8","first-page":"1937","article-title":"Properties of asparagine synthetase in asparagine-independent variants of Jensen rat sarcoma cells induced by 5-azacytidine","volume":"3","author":"Sugiyama","year":"1983","journal-title":"Mol. Cell Biol."},{"key":"ref_9","first-page":"2922","article-title":"DNA methylation patterns associated with asparagine synthetase expression in asparagine-overproducing and -auxotrophic cells","volume":"9","author":"Andrulis","year":"1989","journal-title":"Mol. Cell Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1054\/bjoc.2001.2000","article-title":"Hypermethylation of CpG islands in the mouse asparagine synthetase gene: Relationship to asparaginase sensitivity in lymphoma cells. Partial methylation in normal cells","volume":"85","author":"Peng","year":"2001","journal-title":"Br. J. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1038\/sj.onc.1207498","article-title":"Methylation of the asparagine synthetase promoter in human leukemic cell lines is associated with a specific methyl binding protein","volume":"23","author":"Ren","year":"2004","journal-title":"Oncogene"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"18674","DOI":"10.1074\/jbc.RA119.010447","article-title":"Promoter demethylation of the asparagine synthetase gene is required for ATF4-dependent adaptation to asparagine depletion","volume":"294","author":"Jiang","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/sj.leu.2404216","article-title":"Methylation analysis of asparagine synthetase gene in acute lymphoblastic leukemia cells","volume":"20","author":"Akagi","year":"2006","journal-title":"Leukemia"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1158\/1078-0432.CCR-18-1844","article-title":"Epigenetic silencing affects l-asparaginase sensitivity and predicts outcome in T-ALL","volume":"25","author":"Touzart","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1182\/blood.2019004090","article-title":"Association of aberrant ASNS imprinting with asparaginase sensitivity and chromosomal abnormality in childhood BCP-ALL","volume":"136","author":"Watanabe","year":"2020","journal-title":"Blood"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1182\/bloodadvances.2021004271","article-title":"Association of allele-specific methylation of the ASNS gene with asparaginase sensitivity and prognosis in T-ALL","volume":"6","author":"Akahane","year":"2022","journal-title":"Blood Adv."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/s41591-019-0404-8","article-title":"The landscape of cancer cell line metabolism","volume":"25","author":"Li","year":"2019","journal-title":"Nat. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1146\/annurev.biochem.75.103004.142520","article-title":"Asparagine synthetase chemotherapy","volume":"75","author":"Richards","year":"2006","journal-title":"Annu. Rev. Biochem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"E789","DOI":"10.1152\/ajpendo.00015.2013","article-title":"Asparagine synthetase: Regulation by cell stress and involvement in tumor biology","volume":"304","author":"Balasubramanian","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3945\/an.112.001891","article-title":"The transcription factor network associated with the amino acid response in mammalian cells","volume":"3","author":"Kilberg","year":"2012","journal-title":"Adv. Nutr."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s12276-020-0375-3","article-title":"Amino acids in cancer","volume":"52","author":"Lieu","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"4497","DOI":"10.1128\/MCB.15.8.4497","article-title":"The histidyl-tRNA synthetase-related sequence in the eIF-2 alpha protein kinase GCN2 interacts with tRNA and is required for activation in response to starvation for different amino acids","volume":"15","author":"Wek","year":"1995","journal-title":"Mol. Cell Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"24120","DOI":"10.1074\/jbc.M201959200","article-title":"ATF4 is a mediator of the nutrient-sensing response pathway that activates the human asparagine synthetase gene","volume":"277","author":"Siu","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"36393","DOI":"10.1074\/jbc.M112.399600","article-title":"ATF4-dependent regulation of the JMJD3 gene during amino acid deprivation can be rescued in Atf4-deficient cells by inhibition of deacetylation","volume":"287","author":"Shan","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.tem.2009.05.008","article-title":"ATF4-dependent transcription mediates signaling of amino acid limitation","volume":"20","author":"Kilberg","year":"2009","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S1097-2765(00)00108-8","article-title":"Regulated translation initiation controls stress-induced gene expression in mammalian cells","volume":"6","author":"Harding","year":"2000","journal-title":"Mol. Cell"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"26976","DOI":"10.1016\/S0021-9258(19)61468-7","article-title":"Activation of the human asparagine synthetase gene by the amino acid response and the endoplasmic reticulum stress response pathways occurs by common genomic elements","volume":"275","author":"Chen","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3945\/an.112.002113","article-title":"Eukaryotic initiation factor 2 phosphorylation and translational control in metabolism","volume":"3","author":"Baird","year":"2012","journal-title":"Adv. Nutr."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.ccell.2019.03.004","article-title":"Synthetic Lethality of Wnt Pathway Activation and Asparaginase in Drug-Resistant Acute Leukemias","volume":"35","author":"Hinze","year":"2019","journal-title":"Cancer Cell"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12964-024-01540-x","article-title":"Metabolism of asparagine in the physiological state and cancer","volume":"22","author":"Yuan","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"ref_31","first-page":"294","article-title":"Biochemical characterization of U937 cells resistant to L-asparaginase: The role of asparagine synthetase","volume":"3","author":"Kiriyama","year":"1989","journal-title":"Leukemia"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00280-007-0421-z","article-title":"The inhibition of glutamine synthetase sensitizes human sarcoma cells to L-asparaginase","volume":"60","author":"Tardito","year":"2007","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/bjc.2014.425","article-title":"Glutamine depletion by crisantaspase hinders the growth of human hepatocellular carcinoma xenografts","volume":"111","author":"Chiu","year":"2014","journal-title":"Br. J. Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.tibs.2010.05.003","article-title":"Glutamine addiction: A new therapeutic target in cancer","volume":"35","author":"Wise","year":"2010","journal-title":"Trends Biochem. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1158\/0008-5472.CAN-14-3745","article-title":"Amino Acid transporters in cancer and their relevance to \u201cglutamine addiction\u201d: Novel targets for the design of a new class of anticancer drugs","volume":"75","author":"Bhutia","year":"2015","journal-title":"Cancer Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.tem.2019.03.003","article-title":"Glutamine as an essential amino acid for KRas-driven cancer cells","volume":"30","author":"Bernfeld","year":"2019","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.molcel.2014.08.018","article-title":"Asparagine plays a critical role in regulating cellular adaptation to glutamine depletion","volume":"56","author":"Zhang","year":"2014","journal-title":"Mol. Cell"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/73439","article-title":"A gene expression database for the molecular pharmacology of cancer","volume":"24","author":"Scherf","year":"2000","journal-title":"Nat. Genet."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1158\/1535-7163.MCT-06-0447","article-title":"Asparagine synthetase as a causal, predictive biomarker for L-asparaginase activity in ovarian cancer cells","volume":"5","author":"Lorenzi","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1158\/1535-7163.MCT-08-0589","article-title":"Asparagine synthetase is a predictive biomarker of L-asparaginase activity in ovarian cancer cell lines","volume":"7","author":"Lorenzi","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcmgh.2019.08.003","article-title":"Asparagine Synthetase Is Highly Expressed at Baseline in the Pancreas Through Heightened PERK Signaling","volume":"9","author":"Mukherjee","year":"2020","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1097\/MPA.0b013e318247d903","article-title":"Pancreatic tumor sensitivity to plasma L-asparagine starvation","volume":"41","author":"Dufour","year":"2012","journal-title":"Pancreas"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1158\/0008-5472.CAN-06-2519","article-title":"Enhanced expression of asparagine synthetase under glucose-deprived conditions protects pancreatic cancer cells from apoptosis induced by glucose deprivation and cisplatin","volume":"67","author":"Cui","year":"2007","journal-title":"Cancer Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1038\/s41556-019-0415-1","article-title":"Translational reprogramming marks adaptation to asparagine restriction in cancer","volume":"21","author":"Pathria","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"E7776","DOI":"10.1073\/pnas.1805523115","article-title":"Inhibition of GCN2 sensitizes ASNS-low cancer cells to asparaginase by disrupting the amino acid response","volume":"115","author":"Nakamura","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1080\/00365521.2016.1190399","article-title":"Knockdown of asparagine synthetase (ASNS) suppresses cell proliferation and inhibits tumor growth in gastric cancer cells","volume":"51","author":"Yu","year":"2016","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1038\/s41417-023-00653-8","article-title":"Targeting TLK2 inhibits the progression of gastric cancer by reprogramming amino acid metabolism through the mTOR\/ASNS axis","volume":"30","author":"Wang","year":"2023","journal-title":"Cancer Gene Ther."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12935-024-03279-4","article-title":"Transmembrane protein 176B regulates amino acid metabolism through the PI3K-Akt-mTOR signaling pathway and promotes gastric cancer progression","volume":"24","author":"Li","year":"2024","journal-title":"Cancer Cell Int."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/cgt.2016.28","article-title":"Loss of asparagine synthetase suppresses the growth of human lung cancer cells by arresting cell cycle at G0\/G1 phase","volume":"23","author":"Xu","year":"2016","journal-title":"Cancer Gene Ther."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ccell.2017.12.003","article-title":"Oncogenic KRAS regulates amino acid homeostasis and asparagine biosynthesis via ATF4 and alters sensitivity to L-asparaginase","volume":"33","author":"Gwinn","year":"2018","journal-title":"Cancer Cell"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41419-022-05015-0","article-title":"Asparagine synthetase regulates lung-cancer metastasis by stabilizing the \u03b2-catenin complex and modulating mitochondrial response","volume":"13","author":"Cai","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41419-024-06577-x","article-title":"AURKA emerges as a vulnerable target for KEAP1-deficient non-small cell lung cancer by activation of asparagine synthesis","volume":"15","author":"Deng","year":"2024","journal-title":"Cell Death Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/carcin\/bgl091","article-title":"Impact of constitutive IGF1\/IGF2 stimulation on the transcriptional program of human breast cancer cells","volume":"28","author":"Pacher","year":"2007","journal-title":"Carcinogenesis"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/cbdd.12348","article-title":"Down-regulation of asparagine synthetase induces cell cycle arrest and inhibits cell proliferation of breast cancer","volume":"84","author":"Yang","year":"2014","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cmet.2017.12.006","article-title":"As extracellular glutamine levels decline, asparagine becomes an essential amino acid","volume":"27","author":"Pavlova","year":"2018","journal-title":"Cell Metab."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nature25465","article-title":"Asparagine bioavailability governs metastasis in a model of breast cancer","volume":"554","author":"Knott","year":"2018","journal-title":"Nature"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/sj.bjc.6605491","article-title":"Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype","volume":"102","author":"Ameri","year":"2010","journal-title":"Br. J. Cancer"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1080\/15548627.2018.1450708","article-title":"Autophagic reliance promotes metabolic reprogramming in oncogenic KRAS-driven tumorigenesis","volume":"14","author":"Lin","year":"2018","journal-title":"Autophagy"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1038\/emboj.2010.81","article-title":"The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation","volume":"29","author":"Ye","year":"2010","journal-title":"EMBO J."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"6823","DOI":"10.1007\/s13277-014-1895-z","article-title":"Deficiency in asparagine synthetase expression in rectal cancers receiving concurrent chemoradiotherapy: Negative prognostic impact and therapeutic relevance","volume":"35","author":"Lin","year":"2014","journal-title":"Tumour Biol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.neo.2016.09.004","article-title":"Metabolic alterations caused by KRAS mutations in colorectal cancer contribute to cell adaptation to glutamine depletion by upregulation of asparagine synthetase","volume":"18","author":"Toda","year":"2016","journal-title":"Neoplasia"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Nishikawa, G., Kawada, K., Hanada, K., Maekawa, H., Itatani, Y., Miyoshi, H., Taketo, M.M., and Obama, K. (2022). Targeting asparagine synthetase in tumorgenicity using patient-derived tumor-initiating cells. Cells, 11.","DOI":"10.3390\/cells11203273"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nature12138","article-title":"Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells","volume":"497","author":"Commisso","year":"2013","journal-title":"Nature"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.canlet.2021.09.023","article-title":"Dual blockade of macropinocytosis and asparagine bioavailability shows synergistic anti-tumor effects on KRAS-mutant colorectal cancer","volume":"522","author":"Hanada","year":"2021","journal-title":"Cancer Lett."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41419-019-1481-9","article-title":"SOX12 promotes colorectal cancer cell proliferation and metastasis by regulating asparagine synthesis","volume":"10","author":"Du","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s40246-024-00635-3","article-title":"Growth characteristics of HCT116 xenografts lacking asparagine synthetase vary according to sex","volume":"18","author":"Aladelokun","year":"2024","journal-title":"Hum. Genomics"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.1038\/s41598-020-61851-0","article-title":"Sex differences in colon cancer metabolism reveal a novel subphenotype","volume":"10","author":"Cai","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Shen, X., Cai, Y., Lu, L., Huang, H., Yan, H., Paty, P.B., Muca, E., Ahuja, N., Zhang, Y., and Johnson, C.H. (2022). Asparagine metabolism in tumors is linked to poor survival in females with colorectal cancer: A cohort study. Metabolites, 12.","DOI":"10.3390\/metabo12020164"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1038\/s41467-020-15573-6","article-title":"p53-mediated control of aspartate-asparagine homeostasis dictates LKB1 activity and modulates cell survival","volume":"11","author":"Deng","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1158\/2159-8290.CD-19-1472","article-title":"Exploiting the Therapeutic Interaction of WNT Pathway Activation and Asparaginase for Colorectal Cancer Therapy","volume":"10","author":"Hinze","year":"2020","journal-title":"Cancer Discov."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"102037","DOI":"10.1016\/j.molmet.2024.102037","article-title":"Identifying targetable metabolic dependencies across colorectal cancer progression","volume":"90","author":"Legge","year":"2024","journal-title":"Mol. Metab."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1365-2362.2007.01763.x","article-title":"Expression profiling of PC-3 cell line variants and comparison of MIC-1 transcript levels in benign and malignant prostate","volume":"37","author":"Patrikainen","year":"2007","journal-title":"Eur. J. Clin. Invest."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.ajpath.2011.11.030","article-title":"Integrative molecular profiling reveals asparagine synthetase is a target in castration-resistant prostate cancer","volume":"180","author":"Sircar","year":"2012","journal-title":"Am. J. Pathol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nature16982","article-title":"Tumour-specific proline vulnerability uncovered by differential ribosome codon reading","volume":"530","author":"Rooijers","year":"2016","journal-title":"Nature"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1158\/0008-5472.CAN-23-2910","article-title":"Asparagine Dependency Is a Targetable Metabolic Vulnerability in TP53-Altered Castration-Resistant Prostate Cancer","volume":"84","author":"Yoo","year":"2024","journal-title":"Cancer Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/bjc.2013.293","article-title":"Asparagine synthetase is an independent predictor of surgical survival and a potential therapeutic target in hepatocellular carcinoma","volume":"109","author":"Zhang","year":"2013","journal-title":"Br. J. Cancer"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12876-017-0635-4","article-title":"Polymorphism in asparagine synthetase is associated with overall survival of hepatocellular carcinoma patients","volume":"17","author":"Li","year":"2017","journal-title":"BMC Gastroenterol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1158\/0008-5472.CAN-22-3561","article-title":"PTTG1 Reprograms Asparagine Metabolism to Promote Hepatocellular Carcinoma Progression","volume":"83","author":"Zhou","year":"2023","journal-title":"Cancer Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1016\/j.cell.2023.09.011","article-title":"Arginine reprograms metabolism in liver cancer via RBM39","volume":"186","author":"Mossmann","year":"2023","journal-title":"Cell"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/bab.1383","article-title":"Knockdown of asparagine synthetase by RNAi suppresses cell growth in human melanoma cells and epidermoid carcinoma cells","volume":"63","author":"Li","year":"2016","journal-title":"Biotechnol. Appl. Biochem."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"11457","DOI":"10.1038\/ncomms11457","article-title":"Asparagine promotes cancer cell proliferation through use as an amino acid exchange factor","volume":"7","author":"Krall","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41419-023-06010-9","article-title":"NUCKS1, a LINC00629-upregulated gene, facilitated osteosarcoma progression and metastasis by elevating asparagine synthesis","volume":"14","author":"Zheng","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1038\/onc.2017.59","article-title":"Autophagy is required for cell survival under L-asparaginase-induced metabolic stress in acute lymphoblastic leukemia cells","volume":"36","author":"Takahashi","year":"2017","journal-title":"Oncogene"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"91052","DOI":"10.18632\/oncotarget.19409","article-title":"Autophagy suppression potentiates the anti-glioblastoma effect of asparaginase in vitro and in vivo","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"42664","DOI":"10.18632\/oncotarget.16844","article-title":"Synthetic lethality of glutaminolysis inhibition, autophagy inactivation and asparagine depletion in colon cancer","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1111\/j.1582-4934.2012.01547.x","article-title":"L-asparaginase inhibits invasive and angiogenic activity and induces autophagy in ovarian cancer","volume":"16","author":"Yu","year":"2012","journal-title":"J. Cell Mol. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"5915","DOI":"10.1016\/j.bmc.2012.07.047","article-title":"A sulfoximine-based inhibitor of human asparagine synthetase kills L-asparaginase-resistant leukemia cells","volume":"20","author":"Ikeuchi","year":"2012","journal-title":"Bioorg Med. Chem."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e09436","DOI":"10.7554\/eLife.09436","article-title":"Functional genomic screening reveals asparagine dependence as a metabolic vulnerability in sarcoma","volume":"4","author":"Hettmer","year":"2015","journal-title":"Elife"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"176156","DOI":"10.1016\/j.ejphar.2023.176156","article-title":"Bisabosqual A: A novel asparagine synthetase inhibitor suppressing the proliferation and migration of human non-small cell lung cancer A549 cells","volume":"960","author":"Pan","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s42003-019-0587-z","article-title":"High-resolution crystal structure of human asparagine synthetase enables analysis of inhibitor binding and selectivity","volume":"2","author":"Zhu","year":"2019","journal-title":"Commun. Biol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejca.2019.10.020","article-title":"Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of advanced pancreatic cancer: An open-label, randomized Phase IIb trial","volume":"124","author":"Hammel","year":"2020","journal-title":"Eur. J. Cancer"}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/17\/1\/179\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:22:15Z","timestamp":1759918935000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/17\/1\/179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,3]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["nu17010179"],"URL":"https:\/\/doi.org\/10.3390\/nu17010179","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,3]]}}}